Corneal Confocal Microscopy to Diagnose Peripheral Neuropathy: A Systematic Review and Meta-Analysis
Abstract
Background and objectives: Peripheral neuropathy (PN) may be diagnosed late or may remain undiagnosed. Studies have shown that measurement of corneal nerve fiber length (CNFL) using corneal confocal microscopy (CCM) may have diagnostic utility in diabetic and other peripheral neuropathies.
Methods: The main databases [CENTRAL, Embase (Ovid), and PubMed] were searched for peer-reviewed literature. Gray literature searching was undertaken using the ProQuest Dissertations & Theses database. The updated Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines were used by two authors independently for screening and data extraction. The primary outcome of CNFL was represented by the standardized mean difference and 95% confidence interval, and differences between healthy controls (HC), patients with sub-clinical (PN-), and clinical (PN+) peripheral neuropathy were assessed. Sensitivity analysis was performed to assess the risk of bias.
Results: We identified n = 52 eligible studies (n = 2995 participants) reporting CNFL across 34 different conditions associated with PN. CNFL was significantly lower in PN+ patients compared to HC (standardized mean difference -1.12, 95% confidence interval -1.32 to -0.33, p < 0.00001), in PN- patients compared to HC (-0.78, -0.99 to -0.57, p < 0.00001), and in PN+ compared to PN- patients (-0.93, -1.53 to -0.33, p = 0.002). The results remained significant following sensitivity analysis to adjust for the risk of potential…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 2,995 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.